FDA issued guidances on Remote Digital Pathology and Non-invasive Fetal and Maternal Monitoring devices
FDA issued guidances to provide a policy to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides and non-invasive fetal and maternal monitoring devices during COVID-19 pandemic. Enforcement Policy for [...]
















